basement membrane by 1 mm or less. 3 This type of DCIS is most common in high-grade DCIS lesions. 3 Ductal carcinoma in situ is a heterogeneous group of lesions with diverse imaging, morphologic, and biological features. Studies have shown that up to 50% of DCIS lesions will progress to invasive breast carcinoma, but there is tremendous variability in the rate of progression. 4 Ductal carcinoma in situ with microinvasion is considered to represent the interim stage. 3, 4 Differentiation of DCIS with microinvasion from pure DCIS by preoperative imaging may have prognostic value and help guide clinical treatment. Although mammography and magnetic resonance imaging can identify DCIS, sonography has value as a screening tool and as a diagnostic tool because it is widely available, can be performed without a contrast agent, and is well tolerated. 5, 6 Numerous studies 3, [5] [6] [7] have investigated the clinical, pathologic, and imaging characteristics of pure DCIS and DCIS with microinvasion. However, to our knowledge, no large series have compared the sonographic features of pure DCIS and DCIS with microinvasion, and it is unclear whether certain sonographic features are associated with invasiveness. The purpose of this study was to identify the sonographic features, clinicopathologic characteristics, and biomarkers associated with DCIS with microinvasion.
Materials and Methods

Study Population
This retrospective study of images and other data was approved by the Institutional Review Board of our institution. From December 2009 to July 2013, 304 cases of DCIS were identified based on the reference standard of histopathologic findings from lumpectomy or mastectomy specimens. Eighty-six patients were excluded: 52 patients had no evidence of a mass on sonography; 18 patients had associated invasive breast carcinoma, and 2 had associated papillary Paget disease, and they all received neoadjuvant chemotherapy or endocrine therapy before surgery, which altered the sonographic features and size of the DCIS lesions; and 14 patients had indeterminate results for human epidermal growth factor receptor 2 (HER2)/neu status (2+) without fluorescence in situ hybridization. For 9 patients with multifocal lesions and 2 with bilateral disease, we only analyzed the largest lesion. Thus, we analyzed 218 lesions in 218 patients. Clinical data including age and menopausal status were recorded. Three patients who had sentinel lymph node metastases underwent axillary lymph node dissection. All patients were treated by either lumpectomy or mastectomy (all with axillary sentinel lymph node dissection) followed by radiation therapy (for lumpectomy) and adjuvant endocrine therapy (for 152 patients with estrogen receptor [ER]-positive carcinomas) according to standard guidelines.
Sonographic Examinations
Real-time grayscale and color Doppler sonographic examinations were performed with a MyLab 60 or MyLab 90 ultrasound system (Esaote SpA, Genoa, Italy) that was equipped with a 10-15-MHz transducer. The sonographic examinations were performed by 1 or 2 radiologists who had 8 to 17 years of experience in breast sonography. The focus, gain, and depth were adjusted to obtain the best image, and Doppler parameters were optimized to maximize Doppler sensitivity in the absence of any color noise in normal breast tissue. Masses that had suspicious sonographic features were examined according to the 2013 version of the American College of Radiology Breast Imaging Reporting and Data System. 8 The sonographic status of the axilla was documented. All images were recorded and uploaded to a picture archiving and communication system for subsequent analysis.
The grayscale sonographic features considered were shape (round or oval versus irregular), orientation (parallel versus nonparallel to skin), margin (circumscribed versus uncircumscribed), echo pattern (hypoechoic versus complex cystic and solid), posterior acoustic features (shadowing or combined posterior acoustic feature versus no posterior acoustic feature or enhancement), microcalcifications (present versus absent), and duct changes (present versus absent). Uncircumscribed was defined by the presence of an indistinct margin that was spiculated, angular, or microlobulated.
The color Doppler sonographic characteristics were classified by vascularization distribution and degree. The vascularization distribution was classified as mixed (equal peripheral and internal blood flow signals) versus unmixed. Unmixed included none (no blood flow signals), peripheral (main peripheral blood flow signals) and internal (main internal blood flow signals). The vascularization degree was classified as high (at least 2 penetrating vessels present) versus low (no vessels or 1 penetrating vessel). A penetrating vessel was defined as a continuous vascular signal extending from outside to the inside the lesion. 9 Three color Doppler indices (peak systolic velocity [PSV], pulsatility index [PI] , and resistive index [RI]) were used for comparisons. Among the 218 examined lesions, these data could be obtained for 3 different arteries in 88 lesions (40.4%). Elasticity assessment features were not included in this analysis because this parameter was not used routinely during the study period.
Histologic Analysis
All tumor specimens entered into this study were reevaluated by a single pathologist (X.-C.F., with 11 years of experience in breast diseases). Ductal carcinoma in situ with microinvasion was defined by the presence of 1 or more foci of invasive carcinoma that were 1 mm or less in the greatest dimension within the area of DCIS. The dimensions were measured by examination of serial sections. According to the Van Nuys classification, specimens were classified as high nuclear grade (grade 3), nonhigh nuclear grade with necrosis (grade 2), and nonhigh nuclear grade without necrosis (grade 1). 10 The following biological markers were examined by immunohistochemistry analysis as part of the routine pathologic assessment in our institution: ER, progesterone receptor (PR), HER2, and Ki-67 index. Positivity for ER and PR was defined as nuclear staining in 10% or more of tumor cells. Human epidermal growth factor receptor 2/neu was tested by immunohistochemistry and fluorescence in situ hybridization, and HER2/neu status was graded as 0, 1+, 2+, and 3+ by immunohistochemistry: HER2/neu 3+ was considered HER2 positive, whereas HER2/neu 0 and HER2/neu 1+ were considered HER2 negative. In this study, 24 HER2/neu 2+ cases were further assessed by fluorescence in situ hybridization. On fluorescence in situ hybridization, an HER2 gene copy number per chromosome 17 centromere ratio of greater 2.2 was consistent with gene amplification, and less than 1.8 was considered unamplified. A ratio between 1.8 and 2.2 was considered equivocal. In our data, 16 cases of HER2 gene amplification were considered positive; 8 cases without HER2 gene amplification were considered negative; and no case was considered equivocal. The Ki-67 labeling index was defined as the percentage of tumor cells that had nuclear staining. An estimated percentage of Ki-67-positive cells was determined, and a cutoff for positivity was established at 20%. 11 
Statistical Analysis
The χ 2 test, Fisher exact test, and Student t test were used to evaluate the significance of relationships between the presence of DCIS with microinvasion and clinicopathologic findings, biomarkers, and sonographic features. Multivariate logistic regression analysis was used to calculate the odds ratio (OR) and 95% confidence intervals (CI) in analysis of sonographic findings that were significant in univariate analysis. χ 2 tests were also used for analysis of correlations. P ≤ .05 was considered statistically significant. Data analysis was performed with SPSS version 17.0 statistical software (IBM Corporation, Armonk, NY).
Results
We retrospectively analyzed the records of 218 patients, 160 with pure DCIS and 58 with DCIS with microinvasion ( Table 1 ). All patients were female, with a mean age of 55.3 years (range, 32-78 years). The mean tumor size was 2.5 cm (range, 0.5-7.9 cm) based on histologic examination. Figures 1-4 show grayscale and color Doppler sonograms from representative patients with pure DCIS and DCIS with microinvasion. The groups had similar age and menopausal status (both P > .05). However, patients with DCIS with microinvasion were more likely to have sentinel lymph node metastases, larger tumors, high-grade tumors, HER2 positivity, and a high Ki-67 index (all P < .05). Table 2 shows the results of univariate regression analysis of the grayscale sonographic findings in the patient groups. Hypoechoic echogenicity (67.2% versus 48.8%) and the presence of microcalcifications (69.0% versus Data are presented as mean ± SD and number (percent).
35.0%) were significantly more common in the DCIS with microinvasion group (both P < .05). Analysis of the color Doppler sonographic results indicated that a mixed vascularization distribution (55.2% versus 38.8%) and a high degree of vascularization (62.1% versus 32.5%) were significantly more common in the DCIS with microinvasion group (both P < .05). However, the PSV, PI, and RI were similar in the groups (all P > .05; Table 3 ). Multivariate analysis indicated that the presence of microcalcifications (P < .001; OR, 2.824; 95% CI, 1.733-4.599) and a high degree of vascularization (P < .001; OR, 2.417; 95% CI, 1.531-3.814) were significantly and independently associated with microinvasion (Table 4) . Table 5 shows the association between sonographic features and clinicopathologic findings and biomarkers. The presence of microcalcifications correlated with a high tumor grade and HER2-positive lesions (both P < .05). Moreover, a high degree of vascularization correlated with lymph node metastases, larger tumors, a high tumor grade, and a high Ki-67 index (all P < .05). 
Discussion
Breast DCIS is a heterogeneous noninvasive malignancy. 2, 4 Previous studies of DCIS with microinvasion indicated that lymph node metastases, high-grade lesions, and comedo necrosis were associated with a poor prognosis. [12] [13] [14] Analysis of biomarkers in patients with pure DCIS and DCIS with microinvasion has produced varied results. Zhang et al 15 reported that HER2-positive lesions were more common in pure DCIS than in DCIS with microinvasion. However, Okumura et al 16 reported no differences in expression of ER, PR, and HER2 in pure DCIS and DCIS with microinvasion but a tendency for a higher Ki-67 index in DCIS with microinvasion. Assessment of Ki-67 has been controversial because some studies have used 10% or 20% cutoff points, but others based the cutoff point on the mean or median value. In our study, we used the method of Penault-Llorca et al, 11 with a cutoff for positivity of 20% positive cells. Our results indicated that patients with DCIS with microinvasion were more likely to be HER2 positive and to have a higher Ki-67 index than those with pure DCIS. Pathologic analysis indicated that DCIS with microinvasion was associated with a high tumor grade, larger tumors, and sentinel lymph node metastases. Our study confirmed that DCIS with microinvasion is more strongly associated with the presence of poor prognostic factors than pure DCIS.
Previous studies 5, 6 reported that the sonographic features of DCIS included the presence of architectural distortion, intracystic lesions, and hypoechoic vascular masses. Gwak et al 17 classified the sonographic findings of DCIS as masses, nonmass lesions, or negative findings on sonography. A few studies have compared the sonographic features of pure DCIS with those of DCIS with microinvasion. Our study only investigated DCIS lesions as masses on sonography. The reasons for this choice were that the purpose of this study was to investigate the sonographic features of pure DCIS and DCIS with microinvasion according to Breast Imaging Reporting and Data System sonographic criteria, which mainly classify mass lesions, and DCIS cases manifesting as masses on sonography were more likely to have an invasive component than nonmass lesions. The results of our analysis showed that hypoechoic echogenicity and a mixed vascularization distribution were more common in DCIS with microinvasion than in pure DICS. However, multivariate analysis indicated that neither hypoechoic echogenicity nor a mixed vascularization distribution had an association with microinvasion. Multivariate analysis indicated that the presence of microcalcifications and a high degree of vascularization were significantly and independently associated with microinvasion.
The presence of microcalcifications is the most common characteristic of DCIS based on mammography, and sonography is less sensitive than mammography in the identification of microcalcifications. 17, 18 In particular, it is difficult to identify isolated microcalcifications within normal breast tissue on sonography because breast tissue consists of hyperechoic and heterogeneous fibrous regions. However, microcalcifications within breast masses are easily seen on sonography. 5, 6, 19 In 1988, Kasumi 20 reported sonographic detection of microcalcifications within breast carcinomas. Other sonographic research reported the presence of microcalcifications in 54% to 74% of patients with DCIS. 19, 21 Microcalcifications are also associated with a high nuclear grade and necrosis. 3, 18, 21 The pathogenesis of DCIS with microinvasion may be related to the rapid growth and active metabolism of tumors, in which oxygen and nutrition are insufficient, leading to the development of local ischemic necrosis and calcium salt deposition, which is detected as microcalcifications. Studies of biomarkers indicated that HER2 positivity was an independent predictor of DCIS with microinvasion, and HER2 overexpression was associated with the transition from DCIS to invasive disease. 13, 22 Kim et al 23 reported that expression of the HER2/neu oncogene strongly correlated with the presence of calcifications in breast cancer based on sonography. In agreement, our results indicated that the presence of microcalcifications was significantly more common in DCIS with microinvasion than in pure DCIS. Consistent with the previous finding that HER2 positivity was an independent predictor of DCIS with microinvasion, we also found correlations between a high tumor grade and HER2 positivity. Thus, we suggest that a DCIS lesion that manifests as a mass and that has microcalcifications on sonography is more likely to have microinvasion. There is considerable evidence that angiogenesis plays an essential role in tumor growth and proliferation. In particular, initial color Doppler sonographic studies of breast masses demonstrated that breast cancers as small as 1 mm were likely to have abnormal blood flow patterns. 24 However, it is controversial whether blood flow patterns are related to DCIS progression. Adler et al 25 reported that vascular patterns in DCIS did not correlate with aggressive behavior, but Busilacchi et al 26 found that intratumoral blood flow correlated with the histologic grade. In our study, we classified the color Doppler sonographic features according to vascularization. The results showed that the a mixed vascularization distribution (equal peripheral and internal blood flow signals) was more common in DCIS with microinvasion (55.2%) than in pure DCIS (38.8%), although multivariate analysis indicated that the mixed vascularization distribution had no association with microinvasion. Our examination of vascularization indicated that blood flow within the DCIS mass was always higher than in the surrounding breast tissue. The best method for comparison of the degree of vascularization in pure DCIS and DCIS with microinvasion is unresolved. Microvessel density is accepted as the reference standard for evaluation of tumor angiogenesis. 27 However, microvessel density is evaluated in highly vascularized tumor areas (hot spots) by immunohistochemical assays using panendothelial antibodies. The microvessel density assessment methods are difficult, and the panendothelial antibodies are expensive. Other studies have reported that penetrating vessels have a high correlation with high microvessel density, and the specificity of penetrating vessels in breast tumors is as high as 88.6%. 28 In our study, penetrating vessels were present in 91.3% of DCIS masses (199 of 218). We defined a "high vascularization degree" as the presence of at least 2 penetrating vessels from outside to inside the mass. Our results also showed that a high degree of vascularization was significantly more common in DCIS with microinvasion (62.1%) than in pure DCIS (32.5%), and this difference remained significant in multivariate analysis (P < .001). Furthermore, we also found that a high degree of vascularization correlated with a variety of prognostic factors, including sentinel lymph node metastases, larger tumors, a high tumor grade, and a high Ki-67 index. Previous research 27 suggested that angiogenic factors produced by tumor cells can affect endothelial cells of the surrounding blood vessels. A higher peripheral vessel-tocentral vessel ratio may explain the clinical importance of the presence of penetrating vessels. In particular, more penetrating vessels are essential for tumor cell proliferation. The tumor cells are small and normal appearing initially.
Then, with tumor cell proliferation, irregularly shaped, rapidly dividing cells grow as a solid mass and greatly expand the ducts, with abundant necrosis in the center. These DCIS lesions may be larger, have a higher tumor grade, and be more likely to undergo microinvasion. High Ki-67 expression and lymph node metastases are also associated with high tumor cell proliferation. Our sonographic analysis suggested that the presence of 2 or more penetrating vessels in DCIS lesions was associated with microinvasion, larger tumors, sentinel lymph node metastases, a high tumor grade, and high Ki-67 expression.
There is no question that the color Doppler sonographic indices (PSV, PI, and RI) can help differentiate benign from malignant breast lesions, but they are rarely applied in predicting invasion and prognosis. In 1998, Fu et al 29 reported that malignant neoplasms had a higher RI (>0.7) and PI (>1.30) than benign lesions. In our study, the mean RI values in pure DCIS and DCIS with microinvasion were 0.75 and 0.77, respectively, and the mean PI values were 1.64 and 1.73. These differences were not statistically significant. Our results may have differed from previous results because of our small sample size. In our sonographic study of 218 lesions, pulsed Doppler spectra could be obtained in 3 different arteries within the masses of only 88 lesions. Thus, further studies with larger sample sizes are needed to determine whether the PSV, PI, and RI have a potential impact on determining the presence of DCIS with microinvasion.
Our study had several limitations. First, it was retrospective in design; therefore, the study may have been affected by a selection bias because we only included DCIS cases that appeared as masses based on sonography, and DCIS cases that were nonmass lesions or negative on sonography were excluded. Second, we did not consider some important clinical data, such as clinical symptoms, family history, and history of breast disease, because these data were not generally available. Third, our study only used conventional sonography, not 3-dimensional sonography, elastography, or contrast-enhanced Doppler sonography, to compare pure DCIS and DCIS with microinvasion.
In conclusion, our comparison of the sonographic results for pure DCIS and DCIS with microinvasion indicated that DCIS with microinvasion was more likely to have microcalcifications in a mass and a high degree of vascularization. Patients with these sonographic features also tended to have worse prognostic factors, which should alert the clinician to the possibility of microinvasion and guide appropriate management. Additional larger prospective studies are clearly needed to further examine these issues.
